Trafermin
- Generic Name
- Trafermin
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 131094-16-1
- Unique Ingredient Identifier
- 333OX80X87
- Indication
Investigated for use/treatment in coronary artery disease, peripheral vascular disease, periodontal disease, bone fractures, entero-related fistulae, and diabetic foot ulcers.
- Associated Conditions
- -
- Associated Therapies
- -
A Study to Assess the Safety of Using Fibroblast Growth Factor-2 With Periodontal Surgery in Japan (Phase 3)
- First Posted Date
- 2009-11-18
- Last Posted Date
- 2013-10-21
- Lead Sponsor
- Kaken Pharmaceutical
- Target Recruit Count
- 25
- Registration Number
- NCT01015404
- Locations
- 🇯🇵
Kaken Investigational Site 2, Matsudo, Japan
🇯🇵Kaken Investigational Site 1, Sapporo, Japan
🇯🇵Kaken Investigational Site 4, Shinjuku-ku, Japan
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath